Skip navigation.
ISANH

Related events

Order Abstracts Book
ISANH
 

Targeting Microbiota 2018 - 6th World Congress | Who is attending | Key dates

07/25/2018


 

 
The 6th World Congress on Targeting Microbiota will be held in Porto at Hotel Crowne Plaza on October 28-30, 2018.

Who is attending Targeting Microbiota 2018?

Unifarco
Eurofins Biomnis
Pierre Frabre Dermo-Cosmétique
Ipsen Pharma
Boehringer Ingelheim Pharma
Silab
Beneo-Orafti
Zymo Research Europe
Baylor College of Medicine
Ceitec MU
St. Olav university Hospital
Clinic Coltea Hospital
CNRS-UMR8204
BVBA
Masaryk University
McGill University
McMaster University
Unifarco
Eurofins Biomnis
Pierre Frabre Dermo-Cosmétique
Ipsen Pharma
Boehringer Ingelheim Pharma
Silab
Beneo-Orafti
Pharmaceutical Biotechnology
Poznan University of Medical Sciences
Xiamen University
and more...
For complete list of attendees, please click here
Preliminary Agenda
 
Targeting Microbiota preliminary agenda

Introduction note by President of ISM Targeting Microbiota 2018
Peter Konturek, Teaching Hospital of the University of Jena, Germany

Microbiota and mitochondria inter-talk in hemodialysis patients
Marvin Edeas, Université Paris Descartes, Institut Cochin, France

Honor the lodgers? – Interaction between the built environment microbiome and the human microbiome (Skin & Gut)
Markus Egert, Furtwangen University, Germany
 
Impact of Antibiotics and microbiota: recent scientific advances and perspectives
Maria Vehreschild, University Hospital of Cologne, Germany
 
Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Sara Federici, Weizmann Institute of Science, Israel
 
Recent advances on gut microbiota and food intolerances
Yurdagül Zopf, University of Erlangen-Nuremberg, Germany
                 
Exploring the role of gut dysbiosis in neuroinflammation and hypertension
David Durgan, Baylor College of Medicine, USA

Role of microbes in stem cells transplantation related complication
Ernst Holler, University Hospital Regensburg, Germany

Crosstalk between gut microbiota, innate immune cells and endocrine cells in the pancreas regulates autoimmune diabetes
Julien Diana, INSERM, France

MAIT cells (Mucosal-Associated Invariant T cells) in liver disease and antibacterial response
Antonio Riva, Institute of Hepatology London, Foundation for Liver Research, United Kingdom
                 
The effect of gut bacterial metabolites on cardiovascular risk
Marcin Ufnal, Medical University of Warsaw, Poland
 
Psycho neuro immunology and gut microbes
Paul Forsythe, McMaster University, Canada
 
Targeted gut Microbiota and short chain fatty acid profile among term and preterm infants
Jan Mazela, Poznan University of Medical Sciences, Poland

Fecal Microbiota Transplant 2018: What’s next?
Peter Konturek, Teaching Hospital of the University of Jena, Germany
 
Phage therapy strategy to modulate the child stunting microbiota
Mohammadali Khan Mirzaei, McGill University, Canada

Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency-mediated chronic pain
Francesca Guida, Università degli Studi della Campania “Luigi Vanvitelli”, Italy

Register here
 
Submit your abstract to present your innovative research
Submit your abstract
So, I hope to meet you at the next meeting in order to capture moments of relationship and scientific inspirations by the many and best scientists we have in the world studying the various aspects of the microbiota.

Prof. Peter Konturek
Teaching Hospital of the University of Jena, Germany
President of the International Society of Microbiota

www.microbiota-site.com